Statement from Innovative Medicines Canada on the passage of Bill C-64, the Pharmacare Act
With the passage of the Pharmacare Act, Innovative Medicines Canada remains concerned that the pharmacare program as outlined in the […]
Newsroom
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca or 613-462-5367.
PRESS RELEASES
Statement from Innovative Medicines Canada in response to Minister Holland’s letter to SOCI
“Minister Holland’s recent letter to SOCI regarding the impact of Bill C-64 on private insurance in Canada confirms our concerns: […]
IMC welcomes the Government of Canada’s announcement on the Launch of Health Emergency Readiness Canada (HERC)
Ottawa, September 25, 2024 – Innovative Medicines Canada (IMC) welcomes the announcement of the federal government’s commitment to safeguarding the […]
IN THE NEWS
COMMENTARY: Canadians making desperate choices with limited clinical trials access
This article originally appeared in Saltwire newspapers across Atlantic Canada on July 11, 2024. Dr. P.J. Devereaux, co-chair of Accelerating Clinical Trials […]
Leading the way: Empowering women leaders in Canada’s pharma sector
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
A year later, none of the $1.5B for rare disease has flowed to patients
Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
Patient Stories
Contact
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
Sponsorship Applications
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
JOIN MEDIA LIST
Be the first to get our news
Sign up to our newsletter to get our latest news and updates.
